Letrozole Tablet, Film Coated
Product Images NDC 63629-7819

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 63629-7819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636297819)

This is a description for Letrozole 2.5mg, a yellow round tablet packaged by Bryant Ranch Prepack Burkbank. It has an NDC of 6362978191 and an expiration date of MM/YY. It is recommended to be stored at room temperature (20°-25°C or 68°-77°F) and kept out of reach of children. This medication is comparable to Femara 2.5mg Tablet and is sold in a package of 30 tablets.*

FDA Label Image

Figure 1 Disease-free Survival (median Follow-up 73 Months, Itt Approach) (Letrozole Fig1)

FDA Label Image

Figure 2 Kaplan-meier Estimates Of Time To Progression (tamoxifen Study) (Letrozole Fig2)

FDA Label Image

Figure 3 Survival By Randomized Treatment Arm (Letrozole Fig3)

FDA Label Image

Figure 4 Kaplan-meier Estimates Of Time To Progression (megestrol Acetate Study) (Letrozole Fig4)

FDA Label Image

Figure 5 Kaplan-meier Estimates Of Time To Progression (aminoglutethimide Study) (Letrozole Fig5)

FDA Label Image

Letrozole Structural Formula (Letrozole Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.